Hong Kong pharmaceutical products review committee makes recommendations

06 January 2010

The Review Committee on the Regulation of Pharmaceutical Products in Hong Kong, which is tasked to strengthen the regulatory regime of pharmaceutical products, has put forward 75 recommendations to the government after a nine-month study. For more information, click here.

Back

Support for your business

Sign up for EAS' European Regulatory Briefing »

Legislation update!

HOW TO Apply the Nutrition and Health Claims Regulation


EAS - European Advisory Services